{“posts”:[{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Uncovering Mutant TP53 Dependencies in Spontaneously-Arising Triple-Negative Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Breast”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Resistance to PARP Inhibitor Plus Anti-PD1 Therapy Driven by ER Stress and Bioactive Lipids in Ovarian Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Immunomodulation to Treat Poor-Prognosis Pediatric Brain Tumors”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Targeting Epigenetic Dysregulation in Pediatric Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/trials/pediatric-epigenetics”,”grant_term”:”2019″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Precision Combinatorial Immunotherapeutic Targeting of Thymic Stromal Lymphopoietin Receptor (TSLPR) Signaling in Pediatric and Young Adult CRLF2-Rearranged ALL”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Leukemia (all types), Pediatric – Blood Related”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Antigenicity of Mutant Kras and Impact on Cancer Evolution”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Non – site Specific”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Non-invasive Monitoring of Tumor Phenotype by Interrogation of Plasma Cell Free RNA”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Lung”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: McArthur & Formenti”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Immunotherapy, Radiation Therapy”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Clinical Translation of Novel Immune-Based Combination Therapies for Pediatric Hypermutant Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Leukemia (all types), Liver, Lung, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Other, Ovarian, Pancreatic, Pediatric – Blood Related, Pediatric – Solid Tumor, Prostate, Sarcoma, Stomach, Testicular”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Canada Metastatic Breast Cancer Dream Team: Targeting mRNA Translation To Effectively Treat Metastatic Breast Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/ca/the-science/metastatic_breast_cancer_dream_team/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”Pancreatic Cancer Collective Research Team: Computational Approaches To Identifying High-Risk Pancreatic Cancer Populations – Identifying Individuals at High Risk of Pancreatic Cancer through Machine Learning Analysis of Clinical Records and Images”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/pcc-ai-identifying-individuals/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Computational Approaches To Identifying High-Risk Pancreatic Cancer Populations – Identification of Genomic and Immune Factors in High-Risk Populations for Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/pcc-ai-genomic-immune-factors/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Meg Vosburg T-cell Lymphoma Dream Team: Tailoring CAR-based Immunotherapy Strategies to T-cell Lymphoma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/t-cell-lymphoma-dream-team/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Lymphoma”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”Pancreatic Cancer Collective Research Team: Adoptive Transfer of TGF-β Resistant TIL to Defeat Immunosuppressive PDAC”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/adoptive-transfer/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Molecularly Targeted Radionuclide Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/molecularly-targeted-radionuclide-therapy/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Radiation Therapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Immunotherapy Targeting Mutant KRAS”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/immunotherapy-targeting-mutant-kras/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Combined Targeting of MEK1/MEK2 and Autophagy for Pancreatic Cancer Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/combined-targeting-and-autophagy-for-pancreatic-cancer/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Exploiting DNA Repair Gene Mutations in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/exploiting-dna-repair/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Targeting SHP2 in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/targeting-shp2/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Targeting Stem Cell Signals in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/targeting-stem-cell-signals/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Research Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Interrogating Impact of Epigenetic Modifiers on Durable Reprogramming of Exhausted CD8 T Cells in Patients with NSCLC Treated with PD-1 Blockade”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–Lustgarten Foundation For Pancreatic Research Interception Research Team: Developing Novel Approaches to Treat and Evaluate Early Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/pancreatic-cancer-interception-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other, Radiation Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Defining Effective T-Cell Response in Viral and Non-Viral Gynecologic Cancers”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Cervical, Ovarian”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Characterizing Immuno-variability in Children Following Standard of Care Treatment to Enable Precision Assignment to Immunotherapy Trials”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Cupid-Seq-High Throughput Transcriptomic Spatial Mapping of Immune-Tumor Interactions in the Micro-Environment”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Studies of Colorectal Cancer Patient-Derived Organoids to Validate Candidate Biomarkers of Resistance to Natural Killer Cells”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Colorectal”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Jonkers & Piwinick-Worms”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”SU2C–LUNGevity Foundation–American Lung Association Lung Cancer Interception Dream Team: Intercept Lung Cancer Through Immune, Imaging, and Molecular Evaluation (InTIME)”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/lung-cancer-interception-intime-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Interception Dream Team: Intercepting Pancreatic Cancer in High-Risk Cohorts”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/pancreatic-interception-high-risk-cohorts-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Single-Cell Multi-omics Convergence Research Team: Single-Cell Functional Multi-omics to Characterize and Monitor CAR T Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/single-cell-multi-omics-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Leukemia (all types), Lymphoma”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Cancer Susceptibility Convergence Research Team: Correlating Immunological Health to Cancer Susceptibility”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/cancer-susceptibility-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:””,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Endometrial Cancers Convergence Research Team: Responders and Nonresponders to Endometrial Cancers With Mismatch Repair Deficiencies”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/endometrial-cancers-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Endometiral/Uterin”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Multiple Myeloma Dream Team: Screening and Interception of Precursor Myeloma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/precursor-myeloma-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Multiple Myeloma”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Convergence Research Team: Computational Deconstruction of Neoantigen-TCR Degeneracy for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/neoantigen-tcr-degeneracy-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Natural Killer Cells Convergence Research Team: Integrating Experimental and Computational Pipelines to Develop Biomarkers of Tumor Cell Resistance to NK Cells”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/natural-killer-cells-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:””,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Machine Learning for Immunotherapy Convergence Research Team: Machine Learning for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/machine-learning-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Gynecologic Cancers Convergence Research Team: Connecting Immune Health and Tumor Biology in Gynecologic Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/gynecologic-cancers-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Endometiral/Uterin”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”St. Baldrick’s Foundation–SU2C Pediatric Cancer Dream Team: Immunogenomics to Create New Therapies for High-Risk Childhood Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/intractable-pediatric-cancers-dream-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–LUNGevity–American Lung Association Lung Cancer Interception Research Team: Blood-Based Early Interception of Lung Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/lung-cancer-interception-research-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Combined Epigenetic Therapy and Pembrolizumab for Advanced Non-Small Cell Lung Cancer (NSCLC)”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Pembrolizumab and Radiation Therapy to improve Outcome in High-Risk Sarcoma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Sarcoma”,”treatment_type_terms_string”:”Immunotherapy, Radiation Therapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Immune-oncology Checkpoint Inhibitors Have Brought About a Paradigm Shift in the Treatment of Multiple Tumor Types”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma, Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Combined Approaches by Immune Checkpoint Inhibition for Hypermutant Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Leukemia (all types), Liver, Lung, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Other, Ovarian, Pancreatic, Pediatric – Blood Related, Pediatric – Solid Tumor, Prostate, Sarcoma, Stomach, Testicular”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Radiation Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Reversing Primary Anti-PD-1 Resistance with Ipilimumab and Nivolumab”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Tumor Infiltrating Lymphocyte Adoptive T Cell Therapy for Non-Small Cell Lung Cancer (NSCLC)”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Immunotherapy to Prevent Progression in Multiple Myeloma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Multiple Myeloma”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Aptamer-based Detection and Binding of Peptide-MHC Complexes”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Dissecting the Epigenetic Mechanisms of Repeat RNA Regulation in Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Probing the Metabolic Interactions Between Tumor and Stroma in Pancreatic Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Targeting VDR to make Pancreatic Cancer Competent for Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: DNA Repair Therapies for Ovarian Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Breast, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Neoadjuvant Therapy for Patients with High-Risk Stage III Melanoma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Overcoming Urothelial Cancer Atezolizumab Resistance by Epigenetic Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Bladder, Kidney, Other”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Immunotherapy Combination Strategies in ER-positive Metastatic Breast Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/progress/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C–Lustgarten Foundation CAR T Research Team: Chimeric Antigen Receptor T Cell (CAR T) Therapy for Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/car-t-therapy-for-pancreatic-cancer-research-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Innovative Research Grant: Reworking Negative Receptor Signals for Improved Anti-glioma T-Cell Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting the Pro-metastatic Niche in the Liver for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Liver, Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identifying and Targeting Mechanisms of Resistance to Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Harnessing Dipeptidyl Peptidase Inhibition for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Rescuing T Cell Function for Immunotherapy of Pediatric Malignancies”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: T cell Immunotherapy for Core Binding Factor Acute Myeloid Leukemia”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Imaging CAR T Cells with a Dual Function PET Reporter Gene”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Potentiating Novel Engineered Cellular Therapies for Solid Tumors”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Delineating the Role of the Microbiome in Modulating Tumor and Host Immunity”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Reprogramming Tumor Immunogenicity With STING-Activating Nanoparticles”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System, Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Colorectal Cancer Dream Team: Targeting Genomic, Metabolic, and Immunological Vulnerabilities of Colorectal Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/colorectal-cancer-vulnerabilities-dream-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Colorectal, Non – site Specific, Pediatric – Blood Related”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”Laura Ziskin Prize: Phosphatidylinositol 3-kinase d Inhibition to Treat Patients With Relapsed or Refractory Follicular Lymphoma”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Lymphoma”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Functional Verification of DNA Repair Mutations in Prostate and Ovary Tumors”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian, Prostate”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Checkpoint Inhibition in Children with Ultra-Mutated Cancer Due to Biallelic Mismatch Repair Deficiency (bMMRD)”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Towards Predictive Models of Immunotherapy Response”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Lung, Melanoma, Non – site Specific, Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Defining the Role of Epigenetics in Chimeric Antigen Receptor T Cell Therapy for CLL”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Fingerprinting the Systemic Microbiome in Plasma to Predict Immunotherapy Outcomes in Melanoma”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C Innovative Research Grant: Algorithmically driven Quantitative Combination Cancer Therapy Engineering”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Uncovering How Rad51 Paralog Mutations Contribute to Cancer Predisposition”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Phospholipid Messengers as Drivers of Dendritic Cell Dysfunction in Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Cellular Plasticity in Individual Basal-Type Breast Cancer Cells”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Metabolic Reprogramming Using Oncolytic Viruses to Improve Immunotherapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Defining the Mechanistic Connections Between Injury, Regeneration, and Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Liver”,”treatment_type_terms_string”:”Epigenetic Therapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Defining the Metabolic Dependencies of Tumors”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Imaging Cell-Level Heterogeneity in Solid Tumors for Personalized Treatment”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Deubiquitinating Enzymes as Novel Anticancer Targets”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: “Weak Links” in Cancer Proteostasis Networks as New Therapeutic Targets”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Multiple Myeloma, Prostate”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C–Cancer Research UK–Lustgarten Foundation Pancreatic Cancer Dream Team: Reprogramming of Transcriptional Circuitry to Control Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/reprogramming-of-pancreatic-cancer-dream-team/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Canada–Canadian Cancer Society Breast Cancer Dream Team: Translational Development of Novel Drugs Targeting Tumor Vulnerabilities”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/ca/su2c-canada-canadian-cancer-society-breast-cancer-dream-team/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–National Science Foundation Drug Combinations Convergence Research Team: Rational Design of Anticancer Drug Combinations with Dynamic Multi-Dimensional Input”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/rational-design-of-anticancer-drug-combinations-convergence-research-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Multiple Myeloma, Other, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C–National Science Foundation–Lustgarten Foundation Pancreatic Cancer Convergence Research Team: Liberating T-Cell Mediated Immunity to Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/mediated-immunity-in-pancreatic-cancer-convergence-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Targeting Epigenetic Plasticity and Drug Resistance in Pediatric Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Identification and Analysis of Prostate Reactive TCRs for T-cell Mediated Adoptive Cellular Immunotherapy of Metastatic Prostate Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Development of a High-Throughput Method to Sceen Drugs with Organoids”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–Breast Cancer Research Foundation Breast Cancer Convergence Research Team: Ecology of the Tumor Microenvironment in Breast Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/breast-cancer-tumor-microenvironment/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”Laura Ziskin Prize: Identification of Drivers of APOBEC3B Function”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Breast, Non – site Specific”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Cross-talk Between Histone H3K4 Mono-methylation and Cancer Metabolism to Explore New Therapeutic Strategies”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Leukemia (all types), Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–National Science Foundation Lung Cancer Convergence Research Team: Genetic, Epigenetic, and Immunological Underpinnings of Cancer Evolution Through Treatment”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/convergence-teams/cancer-evolution-convergence-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Leukemia (all types), Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C–American Cancer Society Lung Cancer Dream Team: Targeting KRAS Mutant Lung Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/targeting-kras-mutant-lung-cancers-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Ovarian Cancer Research Alliance–National Ovarian Cancer Coalition Ovarian Cancer Dream Team: DNA Repair Therapies for Ovarian Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/dna-repair-thearpies-for-ovarian-cancer-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Other, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Dutch Cancer Society Colorectal Cancer Early Detection Dream Team: Molecular Early Detection of Colorectal Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/colorectal-cancer-early-detection-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Colorectal”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Canada Cancer Stem Cell Dream Team: Targeting Brain Tumour Stem Cell Epigenetic and Molecular Networks”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/ca/su2c-canada-cancer-stem-cell-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Brain/Nervous System, Head and Neck, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: cBioPortal for Stand Up To Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: The Intersection of Epigenetic and Immune Checkpoint Therapy”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung, Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Analysis of High-Dimension Single-Cell Data from Cancer Immunotherapy Clinical Trials”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung, Melanoma, Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”The Jim Toth Sr. Breakthrough Lung Cancer Research Award: Clinical trials of epigenetic therapy sensitized patients with advanced non-small cell lung cancer to chemotherapy and immunotherapy”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”The Jim Toth Sr. Breakthrough Lung Cancer Research Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Clinical Development of CFI-400945, a PLK4 Inhibitor, in Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Rational Combination Therapy for ER Positive Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”SU2C–Farrah Fawcett Foundation Human Papillomavirus (HPV) Research Team: Therapeutic CD8 Vaccines Against Conserved E7 HPV Epitopes Identified by MS”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/hpv-research-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Cervical, Colorectal, Head and Neck”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Determinants of Sensitivity and Resistance to MEK-Based Targeted Therapies in NRAS Mutant Melanomas”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Van Andel Institute–SU2C Cancer Epigenetics Dream Team: The Epigenetics Dream Team II”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/epigenetics-dream-team-ii/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Bile Duct, Colorectal, Gall Bladder, Leukemia (all types), Liver, Lung, Multiple Myeloma, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Dream Team: Transforming Pancreatic Cancer to Treatable Disease”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/transforming-pancreatic-cancer-dream-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Dutch Cancer Society Tumor Organoids Dream Team: A New Preclinical Model for Drug Sensitivity Analysis”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/tumor-organoids-preclinical-models-dream-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Colorectal, Pancreatic, Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C−Dutch Cancer Society Translational Research Team: Prospective Use of DNA-Guided Personalized Cancer Treatment”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/research-teams/dna-guided-care-research-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Multiple Myeloma, Other, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C–St. Baldrick’s Foundation Pediatric Cancer Dream Team: Immunogenomics to Create New Therapies for High-Risk Childhood Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/high-risk-pediatric-cancers-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Cancer Research Institute Cancer Immunology Dream Team: Immunologic Checkpoint Blockade and Adoptive Cell Transfer in Cancer Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/immunologic-checkpoint-blockade-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Kidney, Lung, Melanoma, Prostate”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Prostate Cancer Foundation Prostate Dream Team: Targeting Adaptive Pathways in Metastatic Castration-Resistant Prostate Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/metastatic-treatment-resistant-prostate-cancer-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”Laura Ziskin Prize: Epigenetic Therapy Sensitizing Breast Cancer Blockades of DNA Repair”,”type”:”research_project”,”url”:””,”grant_term”:”2012″,”cancer_type_terms_string”:”Breast, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy”,”grant_type_terms_string”:””},{“title”:”SU2C−Prostate Cancer Foundation Prostate Dream Team: Precision Therapy of Advanced Prostate Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/prostate-cancer-precision-therapy-dream-team/”,”grant_term”:”2012″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Melanoma Research Alliance Melanoma Dream Team: Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/melanoma-braf-wildtype-dream-team/”,”grant_term”:”2012″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: Developing New Therapeutic Strategies for Soft-Tissue Sarcoma”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identification and Targeting of Novel Rearrangements in High-Risk ALL”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Inhibiting Innate Resistance to Chemotherapy in Lung Cancer Stem Cells”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Sleeping Cancer Cell”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: A Systems Approach to Understanding Tumor Specific Drug Response”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting MLL in Acute Myeloid Leukemia”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Genetic and Metabolic Networks in T-ALL”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Protein Quality Control for Cancer Therapy”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting PP2A and the Glutamine-Sensing Pathway as Cancer Treatment”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Chimeric RNAs Generated by Trans-Splicing and Their Implications in Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Prostate, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Exome Sequencing of Melanomas With Acquired Resistance to BRAF Inhibitors”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Circulating Tumor Cell Dream Team: Bioengineering and Clinical Applications of Circulating Tumor Cell Chip”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/circulating-tumor-cells-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Other, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Pancreatic Dream Team: Cutting Off the Fuel Supply: A New Approach in the Treatment of Pancreatic Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/cutting-fuel-supply-to-pancreatic-cancer-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Epigenetics Dream Team: Bringing Epigenetic Therapy to the Forefront of Cancer Management”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/epigenetics-therapy-2009-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast, Colorectal, Leukemia (all types), Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C PI3K Dream Team: Targeting the PI3K Pathway in Women’s Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/womens-cancers-pi3k-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast, Endometiral/Uterin, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Other, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: Therapeutically Targeting the Epigenome in Aggressive Pediatric Cancers”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Epigenetic Therapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identifying Solid Tumor Kinase Fusions via Exon Capture and 454 Sequencing”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Head and Neck, Leukemia (all types), Lung, Lymphoma, Melanoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Cancer Cell Specific, Self-Delivering Pro-Drugs”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Breast Cancer Dream Team: An Integrated Approach to Targeting Breast Cancer Molecular Subtypes and Their Resistance Phenotypes”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/dream-teams/breast-cancer-resistant-phenotypes-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: Genetic Approaches for Next Generation of Breast Cancer Tailored Programs”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Endogenous Small Molecules That Regulate Signaling Pathways in Cancer Cells”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Inhibition of BCL6 for Leukemia Stem Cell Eradication”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Leukemia (all types), Pediatric – Blood Related”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Modulating Transcription Factor Abnormalities in Pediatric Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Modeling Ewing Tumor Initiation in Human Neural Crest Stem Cells”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: An Emerging Tumor Suppressor Pathway to Human Cancer”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Liver, Other”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Probing EBV-LMP-1’s Transmembrane Activation Domain With Synthetic Peptide”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Functional Oncogene Identification”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Leukemia (all types), Lymphoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: A Transformative Technology to Capture and Drug New Cancer Targets”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Noninvasive Molecular Profiling of Cancer via Tumor-Derived Microparticles”,”type”:”research_project”,”url”:”https://dev.standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”}],”total_count”:146,”total_pages”:0,”type”:”research_project”}